DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Emens LA, Esteva F, Beresford M. et al
Results from KATE2, a randomized phase 2 study of atezolizumab (atezo) + trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC).
Cancer Res 2019;
79 (Suppl. 04) PD3-01
We do not assume any responsibility for the contents of the web pages of other providers.